Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifluridine/Tipiracil + Irinotecan in Refractory Biliary Tract Cancers
NCT04072445Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in biliary tract cancer (BTC), sponsored by Mayo Clinic. Started Oct 2019; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04072445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072445.